This review presents the evidence on the benefits of fixed-dose combination therapy for arterial hypertension management. The focus is on the combination of a third-generation dihydropyridine calcium antagonist lercanidipine and an ACE inhibitor enalapril. Lercanidipine is characterised by high vascular selectivity and lipophilicity. good antihypertensive effectiveness. https://www.hindigyanvishv.com/super-find-Red-Pygmy-reg-Dogwood-Tree-limited-super/